ICI-174864
ICI-174864
ICI-174864 is a selective antagonist of the 5-HT2 receptor, specifically targeting the 5-HT2A and 5-HT2C subtypes. It is a compound of interest in the field of neuropharmacology due to its potential applications in research and therapeutic contexts.
Chemical Structure and Properties[edit]
ICI-174864 is a chemical compound with the molecular formula C19H22N2O2. It is characterized by its selective binding affinity to the 5-HT2A and 5-HT2C receptors, which are subtypes of the serotonin receptor family. These receptors are G protein-coupled receptors (GPCRs) that play a crucial role in the modulation of neurotransmission in the central nervous system.
Mechanism of Action[edit]
As a selective antagonist, ICI-174864 binds to the 5-HT2A and 5-HT2C receptors, inhibiting the action of serotonin (5-HT) at these sites. This blockade can modulate various physiological and psychological processes, including mood, perception, and cognition. The selective antagonism of these receptors makes ICI-174864 a valuable tool in research for understanding the role of serotonin in the brain.
Research Applications[edit]
ICI-174864 is primarily used in preclinical research to study the function of 5-HT2 receptors. It has been employed in experiments to:
- Investigate the role of 5-HT2 receptors in psychiatric disorders such as schizophrenia, depression, and anxiety disorders.
- Explore the effects of serotonin on cognition and perception.
- Examine the potential therapeutic effects of 5-HT2 receptor modulation in various neurological disorders.
Therapeutic Potential[edit]
While ICI-174864 itself is not used as a therapeutic agent, its role as a research tool helps in the development of new drugs targeting the 5-HT2 receptors. Understanding the interaction between serotonin and these receptors can lead to the development of novel treatments for mental health disorders.
Safety and Toxicology[edit]
As with many research chemicals, the safety profile of ICI-174864 is not fully established for human use. It is primarily used in controlled laboratory settings, and its effects in humans are not well-documented.
